Dieste M C, Hersh P S, Kylstra J A, Larrison W I, Frambach D A, Shingleton B J
Eye Emergency Service, Massachusetts Eye and Ear Infirmary, Boston 02114.
Am J Ophthalmol. 1988 Oct 15;106(4):383-90. doi: 10.1016/0002-9394(88)90871-9.
We treated five patients receiving epsilon-aminocaproic acid who demonstrated sudden and accelerated clot dissolution with accompanying increases in intraocular pressure 24 to 96 hours after discontinuing treatment. All of these patients required additional ocular hypotensive medications and one patient required anterior chamber washout for persistently increased intraocular pressure. These findings suggest that certain patients with hyphema may be at risk for significant intraocular pressure increases following cessation of epsilon-aminocaproic acid therapy.
我们治疗了5例接受ε-氨基己酸治疗的患者,这些患者在停药后24至96小时出现突然且加速的血块溶解,并伴有眼压升高。所有这些患者都需要额外的降眼压药物治疗,1例患者因眼压持续升高需要进行前房冲洗。这些发现表明,某些前房积血患者在停用ε-氨基己酸治疗后可能有眼压显著升高的风险。